Remove Hospitals Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare

pharmaphorum

RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.

Hospitals 118
article thumbnail

A framework for cost-effective and sustainable drug use in hospitals

Hospital Pharmacy Europe

Rising drug costs are putting increasing pressure on healthcare systems, highlighting the need for rational and responsible medicines use, according to a new study looking at cost-effective and sustainable drug use in hospitals. Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach. 2024 Dec 19.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHS strikes another deal with clinical AI company Sensyne Health

pharmaphorum

Sensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Trust (MKUH). The non-exclusive agreement will apply Sensyne’s artificial intelligence technology to anonymised patient data for research into new medicines.

article thumbnail

Portugal: A Study and Comparison Class

Blog: Ask a Student Pharmacist

to improve pharmacy practice and patient care. In Portugal, students visit numerous community pharmacies, a pharmaceutical company, a clinical laboratory, an oncology hospital and a cooperative wholesaling company.

article thumbnail

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

In a crowd of 200 attendees, guests included medical XR start-ups, hospitals, and research universities from around the globe. Additionally, the continued growth of medical XR use by hospitals, physicians, and therapists will allow for scores of new data to be amassed.

article thumbnail

The History and Noble Purpose of the 340B Drug Pricing Program

Omnicell

The 340B Drug Pricing Program enables safety-net providers—select hospitals, clinics, and health centers that serve a disproportionate share of poor patients in these urban and rural areas—to buy prescription drugs at discounted prices. hospitals, they provided 17.4 percent of all uncompensated care, or $6.7

article thumbnail

Is Infectious Disease Pharmacy Right For You?

The Happy PharmD

These pharmacists play pivotal roles in hospitals, not only selecting treatments but also collaborating with healthcare teams and evaluating new therapies. Many practitioners express deep fulfillment in their roles, citing the intellectual stimulation and meaningful impact on patient care.